0:00 0:00 1x

This is read by an automated voice. Please report any issues or inconsistencies here .

The FDA is removing a 22-year-old warning label from hormone-based menopause drugs, saying newer evidence shows benefits outweigh risks for appropriate candidates.

Some doctors say the warning discourages patients who could benefit from the treatment.

Other experts are concerned that the decision lacked sufficient scientific review.

WASHINGTON — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced Monday.

U.S. health officials said they will remove the boxed warning from more than 20 pills, patches and creams co

See Full Page